This category publishes materials on how phages interact with bacteria at the cellular and genetic levels. We cover the latest discoveries, laboratory research, and prospects for the development of phage therapy in the scientific community.
Bacteriophage banks are a new tool in the fight against antibiotic-resistant infections. They provide rapid access to effective treatments, personalized therapy, and pave the way for a global medical revolution. Despite the challenges of phage regulation and selection, their potential already makes phage banks a key area of future medicine.
Phage therapy is not a myth, but a scientifically proven method for treating bacterial infections. Phages act selectively, safely, and effectively, destroying pathogens where antibiotics fail. Today, they are making a comeback in clinical practice and becoming part of the medicine of the future.
The story of the discovery of bacteriophages tells how scientists discovered viruses that infect bacteria, why they were forgotten due to the advent of antibiotics, and why they are being revisited today due to the rise of antibiotic resistance.
Phage therapy is rapidly developing and is already being used in medicine in Georgia, Poland, France, and Ukraine. These countries are demonstrating that bacteriophages can effectively treat resistant infections and offer a safe alternative to antibiotics. Ukraine has all the potential to become a leader in this field.
Invisible helpers of humanity — bacteriophages — are joining the fight against superbugs. The article describes their unique powers, the importance of action aimed at preserving the microbiome, the application of stagnation in medicine and the rural state, as well as new horizons of phage therapy, including phage banks and genetic modification of phages.
Bacteriophages and bacteria have been engaged in an evolutionary race for billions of years. This article addresses the question of whether bacteria can become insensitive to phages, describes the mechanisms of resistance, and emphasizes that loss of sensitivity is often accompanied by a weakening of the bacteria. It also presents strategies for preventing the development of resistance.
Bacteriophages have long been studied in laboratories, but only now are research results beginning to be widely applied in the clinic. This article explores the emerging fields, the drugs already undergoing trials, and why phage therapy is poised to become a part of modern medicine.
